[go: up one dir, main page]

FI80677B - Nya dihydropyridinmellanprodukter. - Google Patents

Nya dihydropyridinmellanprodukter. Download PDF

Info

Publication number
FI80677B
FI80677B FI831778A FI831778A FI80677B FI 80677 B FI80677 B FI 80677B FI 831778 A FI831778 A FI 831778A FI 831778 A FI831778 A FI 831778A FI 80677 B FI80677 B FI 80677B
Authority
FI
Finland
Prior art keywords
dihydropyridine
ethyl
compound
dimethyl
dichlorophenyl
Prior art date
Application number
FI831778A
Other languages
English (en)
Finnish (fi)
Other versions
FI80677C (sv
FI831778L (fi
FI831778A0 (fi
Inventor
Peder Bernhard Berntsson
Stig Aoke Ingemar Carlsson
Bengt Richard Ljung
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of FI831778A0 publication Critical patent/FI831778A0/fi
Publication of FI831778L publication Critical patent/FI831778L/fi
Application granted granted Critical
Publication of FI80677B publication Critical patent/FI80677B/fi
Publication of FI80677C publication Critical patent/FI80677C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Claims (9)

1. Mellanprodukter enligt formeln I, syraadditionsalter eller optiska isomerer därav, R4OOC—.-- " COOAR2 R^^KI^5 H väri R1 betecknar en eller tvä (kan vara olika eller lika) substituenter i fenylringen, vilka är valda ur den grupp som best&r av lägre alkyl, NO2, CN, CF3, Cl och Br; A är en rak eller förgrenad alkylengrupp med 2-5 kolatomer; R2 . R3 är en grupp -S-B-N^ , väri B är en rak eller förgrenad \R6 alkylengrupp med 2-5 kolatomer och R1 och Re är lika eller olika och vardera betecknar en rak eller förgrenad alkyl-grupp med 1-4 kolatomer, bensyl eller de kan tillsammans bilda en morfolinogrupp; R4 är en rak eller förgrenad alkyl-grupp med 1-5 kolatomer eller en sädan rak eller förgrenad alkylgrupp med 1-5 kolatomer, väri kolkedjan är avbruten av en syreatom; och Rs är en alkylgrupp med 1-5 kolatomer.
2. Mellanprodukt enligt patentkrav 1, kännetecknad av att den är föreningen 2,6-dimetyl-4-(2,3-diklorfenyl)-1,4-dihydropyridin-3,5-dikarboxylsyra-3-[2-(2-N,N-dimetylamino-etyltio)etyl]-5-metylester. Mellanprodukt enligt patentkrav 1, kännetecknad av att den är föreningen 2,6-dimetyl-4-(2,3-diklorfenyl)-1,4-dihydropyridin-3,5-dikarboxylsyra-3-[2-(2-N,N-dietylamino-etyltio)etyl]-5-metylester. 33 80677
4. Mellanprodukt enligt patentkrav 1, kännetecknad av att den är föreningen 2,6-dimetyl-4-(2,3-diklorfenyl)-l,4-dihydropyridin-3,5-dikarboxylsyra-3-[2-(2-morfolinoetyl-tio)etyl]-5-metylester.
5. Mellanprodukt enligt patentkrav 1, kännetecknad av att den är föreningen 2,6-dimetyl-4-(2,3-diklorfenyl)-l,4-dihydropyridin-3,5-dikarboxylsyra-3-[2-(2-N-isopropyl-N-bensylaminoetyltio)etyl]-5-metylester.
6. Mellanprodukt enligt patentkrav lf kännetecknad av att den är föreningen 2,6-dimetyl-4-(2,3-diklorfenyl)-l,4-dihydropyridin-3,5-dikarboxylsyra-3-[2-(3-N,N-dimetylamino-propyltio)etyl]-5-metylester.
7. Mellanprodukt enligt nägot av patentkraven 1-6, kännetecknad av att föreningen framställs i form av sin optiska isomer.
8. Mellanprodukt enligt nägot av patentkraven 1-7, kännetecknad av att föreningen framställs i form av sitt syraad-ditionsalt.
9. Mellanprodukt enligt nägot av patentkraven 1-8, ett salt eller optisk isomer därav, kännetecknad av att den används som mellanprodukt vid framställning av terapeutiskt aktiva dihydropyridiner.
FI831778A 1982-05-21 1983-05-19 Nya dihydropyridinmellanprodukter FI80677C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8203176 1982-05-21
SE8203176 1982-05-21

Publications (4)

Publication Number Publication Date
FI831778A0 FI831778A0 (fi) 1983-05-19
FI831778L FI831778L (fi) 1983-11-22
FI80677B true FI80677B (fi) 1990-03-30
FI80677C FI80677C (sv) 1990-07-10

Family

ID=20346867

Family Applications (1)

Application Number Title Priority Date Filing Date
FI831778A FI80677C (sv) 1982-05-21 1983-05-19 Nya dihydropyridinmellanprodukter

Country Status (19)

Country Link
EP (1) EP0095451A3 (sv)
JP (1) JPS58210063A (sv)
KR (1) KR900006682B1 (sv)
AU (1) AU1464583A (sv)
CA (1) CA1205471A (sv)
DD (2) DD209816A5 (sv)
DK (1) DK223683A (sv)
ES (3) ES522570A0 (sv)
FI (1) FI80677C (sv)
GB (1) GB2120668B (sv)
GR (1) GR78566B (sv)
HU (2) HU188342B (sv)
IL (1) IL68524A0 (sv)
IS (1) IS1381B6 (sv)
MW (1) MW1783A1 (sv)
NO (1) NO163327C (sv)
NZ (1) NZ204283A (sv)
PT (1) PT76733B (sv)
ZA (1) ZA833112B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3600594A1 (de) * 1986-01-11 1987-07-16 Bayer Ag Methioninsubstituierte 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung
US4814455A (en) * 1986-04-16 1989-03-21 Bristol-Myers Company Dihydro-3,5-dicarboxylates
JPS63112560A (ja) * 1986-10-29 1988-05-17 Green Cross Corp:The ジヒドロピリジン誘導体
US5310917A (en) * 1991-09-13 1994-05-10 Merck & Co., Inc. Process for the preparation of 4-substituted-1,4-dihydropydrines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2747513A1 (de) * 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen
DE2861974D1 (en) * 1977-11-11 1982-09-16 Ciba Geigy Ag Pyridine dicarboxylic acid derivatives, their mixtures with metallic stabilisers and their use in stabilising chlorine-containing thermoplasts
US4285955A (en) * 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids

Also Published As

Publication number Publication date
ES8504712A1 (es) 1985-05-01
PT76733A (en) 1983-06-01
DK223683D0 (da) 1983-05-19
NO163327C (no) 1990-05-09
NZ204283A (en) 1985-11-08
FI80677C (sv) 1990-07-10
ES535215A0 (es) 1985-05-01
ES8503655A1 (es) 1985-03-16
EP0095451A2 (en) 1983-11-30
PT76733B (en) 1986-03-27
NO163327B (no) 1990-01-29
FI831778L (fi) 1983-11-22
GB2120668A (en) 1983-12-07
IL68524A0 (en) 1983-07-31
FI831778A0 (fi) 1983-05-19
JPS58210063A (ja) 1983-12-07
GR78566B (sv) 1984-09-27
GB2120668B (en) 1985-08-29
DK223683A (da) 1983-11-22
DD216009A5 (de) 1984-11-28
CA1205471A (en) 1986-06-03
IS2809A7 (is) 1983-11-22
GB8314034D0 (en) 1983-06-29
DD209816A5 (de) 1984-05-23
ES535216A0 (es) 1985-05-01
AU1464583A (en) 1983-11-24
KR840004723A (ko) 1984-10-24
NO831806L (no) 1983-11-22
KR900006682B1 (ko) 1990-09-17
HU193786B (en) 1987-11-30
EP0095451A3 (en) 1984-08-29
HU188342B (en) 1986-04-28
ES522570A0 (es) 1985-03-16
MW1783A1 (en) 1985-06-12
ZA833112B (en) 1983-12-28
ES8504713A1 (es) 1985-05-01
IS1381B6 (is) 1989-08-28

Similar Documents

Publication Publication Date Title
FI70573C (fi) Analogifoerfarande foer framstaellning av terapeutiskt aktiv 2,6-dimetyl-4-(2,3-diklorfenyl)-1,4-dihydro- pyridin-3,5-dikarboxylsyra-3-metylester-5-etylester
FI90543B (sv) Förfarande för framställning av som läkemedel användbara dihydropyridinderivat
CN111527077B (zh) 通过添加o,o′-二取代酒石酸对映异构体进行外消旋烟碱的对映异构体分离
FI80677B (fi) Nya dihydropyridinmellanprodukter.
FI60862C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara aminoalkylidenamino-1,4-dihydropyridiner
DE69003936T2 (de) Verfahren zur herstellung von enantiomerreinen polysubstituierten 1,4-dihydropyridinen.
Zhou et al. Synthesis and antihypertensive activity evaluation in spontaneously hypertensive rats of nitrendipine analogues
EP0127826A2 (de) 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
EP0157324A2 (de) Tetrahydrothienopyridine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
CH660593A5 (de) 1,4-dihydropyridindicarbonsaeureester, verfahren zu deren herstellung und pharmazeutische zusammensetzung, enthaltend diese verbindungen als wirkstoff.
DE69131444T2 (de) Optisch aktive 1,4-Dihydropyridinderivate sowie Verfahren zu ihrer Herstellung
US5990121A (en) Use of 1,2-bridged 1,4-dihydropyridines as medicaments
EP0362632A2 (de) Basische 4-Aryl-DHP-amide, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
RU2155751C2 (ru) Производные 1,4-дигидропиридина, смесь их изомеров или отдельные изомеры, фармацевтическая композиция на их основе и 2-хлор-3-цианобензальдегид
DE4134760A1 (de) Aryl-chinolyl-substituierte 1,4-dihydropyridin-dicarbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
JP3751041B2 (ja) 4−(2−クロロ−3−シアノ−フエニル)−1,4−ジヒドロ−2,6−ジメチル−ピリジン−3,5−ジカルボン酸イソプロピル 2−メトキシエチル
US5654461A (en) Sulfamate compound containing carbamoyl group
PL153857B1 (en) Procedure for the production of new derivatives of alkanolamine
NO167455B (no) Mellomprodukter
AT384219B (de) Herstellung von neuen 1,4-dihydropyridinderivaten in optisch aktiver oder racematform
SK166495A3 (en) Pharmacologically effective enantiomers, preparation method threof, intermediate products of this method and use
JPH0655751B2 (ja) ジヒドロピリジンホスホン酸環状エステル
Velázquez-Martínez et al. Syntheses, Calcium Channel Agonist-Antagonist Modulation Activities, and Nitric Oxide Release Studies of...
CH613192A5 (en) Process for the preparation of novel 1,4-dihydropyridine derivatives
EP0347678A2 (de) 1,4-Dihydropyridin-threonin-Derivate und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: AKTIEBOLAGET HAESSLE